Traws Pharma (TRAW) Cash from Operations (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Cash from Operations of 2576000.0 for Q1 2026, up 52.62% year-over-year from 1687841.89 in Q1 2025, and up 6.6% quarter-over-quarter from 2758000.0 in Q4 2025.
Traws Pharma (TRAW) Cash from Operations (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Cash from Operations for 15 consecutive years, with 2576000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 52.62% year-over-year to 2576000.0; the TTM figure through Mar 2026 stood at 15324000.0 (up 50.25% YoY), while the FY2025 annual figure was 18185000.0, up 38.96% from the prior year.
- Cash from Operations climbed to 2576000.0 in Q1 2026 per TRAW's latest filing, from 2758000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2576000.0 in Q1 2026 and bottomed at 11476000.0 in Q3 2024.
- Historically, Cash from Operations has averaged 4987000.0 across 5 years, with a median of 4424000.0 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Operations sank 156.79% — and 2025, when it soared 65.05%.
- Traws Pharma's Cash from Operations stood at 3884000.0 in 2022, then fell by 14.06% to 4430000.0 in 2023, then gained by 8.8% to 4040000.0 in 2024, then jumped by 31.73% to 2758000.0 in 2025, then climbed by 6.6% to 2576000.0 in 2026.
- Business Quant data shows TRAW's Cash from Operations at 2576000.0 in Q1 2026, 2758000.0 in Q4 2025, and 4011000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | -7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.58 Mn |
| Mar 31, 2026 | -2.58 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | -4.01 Mn |
| Sep 30, 2025 | -4.01 Mn |
| Jun 30, 2025 | -5.98 Mn |
| Jun 30, 2025 | -5.98 Mn |
| Mar 31, 2025 | -5.44 Mn |
| Mar 31, 2025 | -5.44 Mn |
| Dec 31, 2024 | -4.04 Mn |
| Dec 31, 2024 | -4.04 Mn |
| Sep 30, 2024 | -11.48 Mn |
| Sep 30, 2024 | -11.48 Mn |
| Jun 30, 2024 | -9.85 Mn |
| Jun 30, 2024 | -9.85 Mn |
| Mar 31, 2024 | -4.42 Mn |
| Mar 31, 2024 | -4.42 Mn |
| Dec 31, 2023 | -4.43 Mn |
| Dec 31, 2023 | -4.43 Mn |